Cargando…
The Current State of MicroRNAs as Restenosis Biomarkers
In-stent restenosis corresponds to the diameter reduction of coronary vessels following percutaneous coronary intervention (PCI), an invasive procedure in which a stent is deployed into the coronary arteries, producing profuse neointimal hyperplasia. The reasons for this process to occur still lack...
Autores principales: | Varela, Nelson, Lanas, Fernando, Salazar, Luis A., Zambrano, Tomás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967329/ https://www.ncbi.nlm.nih.gov/pubmed/31998354 http://dx.doi.org/10.3389/fgene.2019.01247 |
Ejemplares similares
-
MicroRNAs as clinical biomarkers?
por: Angelini, Timothy G., et al.
Publicado: (2015) -
Plasma MicroRNAs as Potential Noninvasive Biomarkers for In-Stent Restenosis
por: He, Meijiao, et al.
Publicado: (2014) -
Roles of microRNAs in atherosclerosis and restenosis
por: Chen, Li-Jing, et al.
Publicado: (2012) -
Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020) -
MicroRNAs as Novel Biomarkers in Colorectal Cancer
por: Hrašovec, Sonja, et al.
Publicado: (2012)